A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

S. A. Ghamande, M. Silverman, M. Gold

Research output: Contribution to journalLetter

Original languageEnglish (US)
Number of pages1
JournalGynecologic Oncology
Volume114
Issue number1
DOIs
Publication statusPublished - Jul 1 2009

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this